科研成果详情

题名The Quality of Randomized Controlled Trials on DanShen in the Treatment of Ischemic Vascular Disease
作者
发表日期2009-05
发表期刊JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE   影响因子和分区
语种英语
原始文献类型Article
其他关键词TRADITIONAL CHINESE MEDICINE ; METHODOLOGICAL QUALITY ; CONSORT STATEMENT ; IMPROVE
摘要Background and objectives: Many randomized controlled trials (RCTs) were conducted to evaluate the efficacy of DanShen (Salvia miltiorrhizae, an herbal medicine) on ischemic vascular diseases (IVD). However, there has been no systematic evaluation of the quality of DanShen RCTs so far. The aims of this study were (1) to assess the quality of DanShen RCTs on IVD published in mainland China from 1998 to 2007 and (2) to explore the factors correlating with the quality. Design: A number of Chinese databases were searched, and most of DanShen RCTs on IVD were collected. According to CONSORT for TCM (Consolidated Standards for Reporting of Trials for Traditional Chinese Medicine) and the Jadad scale, the quality assessment and data abstraction were performed independently by two reviewers. One-way analysis of variance and Pearson correlation analysis were applied to explore the association between basic characteristic and the quality of the RCTs. Results: One hundred and fifty (150) DanShen RCTs were identified finally. The mean (standard deviation) score of 150 DanShen RCTs assessed by CONSORT for TCM was 23.87 (3.68), and 1.94 (0.82) by the Jadad scale, respectively. Only 6.7% (10/150) of RCTs were identified with high quality (Jadad score >= 4). Authors' affiliation, publication journal, sample size, and follow-up time were correlated with the quality of DanShen RCTs. Conclusions: The quality of DanShen RCTs in mainland China has not been improved significantly over recent years, and the overall quality of DanShen RCTs is still poor.
出版者MARY ANN LIEBERT, INC
出版地NEW ROCHELLE
ISSN1075-5535
EISSN1557-7708
卷号15期号:5页码:557-565
DOI10.1089/acm.2008.0436
页数9
WOS类目Integrative & Complementary Medicine
WOS研究方向Integrative & Complementary Medicine
WOS记录号WOS:000266220400018
收录类别SCIE ; PUBMED ; SCOPUS
URL查看原文
PubMed ID19425821
SCOPUSEID2-s2.0-67149146569
通讯作者地址[Zhang, Huaiqing]Department of Cardiovascular Diseases,First Affiliated Hospital,Wenzhou Medical College,No. 2 Fuxue Lane,China
Scopus学科分类Complementary and Alternative Medicine
引用统计
被引频次:14[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/17246
专题附属第一医院_心血管内科
第一临床医学院(信息与工程学院)、附属第一医院_内科学_感染内科
通讯作者Zhang, Huaiqing
作者单位
1.Department of Cardiovascular Diseases,First Affiliated Hospital,Wenzhou Medical College,China;
2.School of Public Health,Peking University,China;
3.Department of Infection and Liver Diseases,First Affiliated Hospital,Wenzhou Medical College,China;
4.Department of Cardiovascular Diseases,First Affiliated Hospital,Wenzhou Medical College,No. 2 Fuxue Lane,China
第一作者单位附属第一医院
通讯作者单位附属第一医院
第一作者的第一单位附属第一医院
推荐引用方式
GB/T 7714
Yu, Shicheng,Zhong, Baoliang,Zheng, Minghua,et al. The Quality of Randomized Controlled Trials on DanShen in the Treatment of Ischemic Vascular Disease[J]. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE,2009,15(5):557-565.
APA Yu, Shicheng, Zhong, Baoliang, Zheng, Minghua, Xiao, Fangyi, Dong, Zhibing, & Zhang, Huaiqing. (2009). The Quality of Randomized Controlled Trials on DanShen in the Treatment of Ischemic Vascular Disease. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 15(5), 557-565.
MLA Yu, Shicheng,et al."The Quality of Randomized Controlled Trials on DanShen in the Treatment of Ischemic Vascular Disease".JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE 15.5(2009):557-565.

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Yu, Shicheng]的文章
[Zhong, Baoliang]的文章
[Zheng, Minghua]的文章
百度学术
百度学术中相似的文章
[Yu, Shicheng]的文章
[Zhong, Baoliang]的文章
[Zheng, Minghua]的文章
必应学术
必应学术中相似的文章
[Yu, Shicheng]的文章
[Zhong, Baoliang]的文章
[Zheng, Minghua]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。